Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes

NCT02447861 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT02447861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02447861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Observational
Overall status
Recruiting
Start date
July 31, 2013
Completion date
January 31, 2028
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microdeletion 3q29 syndrome, microduplication 3q29 syndrome